Correction
5-Aza-Deoxycytidine Induces Selective Degradation of DNA Methyltransferase 1 by a Proteasomal Pathway That Requires the KEN Box, Bromo-Adjacent Homology Domain, and Nuclear Localization Signal
Paper Information
Record ID:
18099
Author(s):
Publication Date:
June 01, 2005
Retraction Date:
April 30, 2018
(7.6 years years ago)
Subjects:
Institution:
Department of Molecular and Cellular Biochemistry, College of Medicine, The Ohio State University, Columbus, OhioCountry:
🇺🇸 United StatesArticle Type:
Publisher:
American Society for Microbiology
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Correction Details
Citations (386)
386
Total Citations111
Post-Retraction(28.8%)
270
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
2
Within 30 days
22
Within 1 year
68
After 2+ years
2321
Days since retraction (latest)
Formaldehyde and De/Methylation in Age-Related Cognitive Impairment
Ting Li, Wei Yan, Meihua Qu et al. (8 authors)
Genes
Open Access
Published: Jun 2021
29 citations
29 citations
1140 days after retraction
Leveraging epigenetics to enhance the efficacy of immunotherapy
Jonathan D. Licht, Richard L. Bennett
Clinical Epigenetics
Open Access
Published: May 2021
38 citations
38 citations
1113 days after retraction
Hypomethylating agents (HMA) for the treatment of acute myeloid leukemia and myelodysplastic syndromes: mechanisms of resistance and novel HMA-based therapies
Julia Stomper, John Charles Rotondo, Gabriele Greve et al. (4 authors)
Leukemia
Open Access
Published: May 2021
161 citations
161 citations
1102 days after retraction
Hypermethylation of Hepatic Mitochondrial <i>ND6</i> Provokes Systemic Insulin Resistance
Ke Cao, Weiqiang Lv, Xueqiang Wang et al. (17 authors)
Advanced Science
Open Access
Published: May 2021
34 citations
34 citations
1098 days after retraction
Targeting epigenetic mechanisms to overcome venetoclax resistance
Gabriel Prado, Charlotte L Kaestner, Jonathan D. Licht et al. (4 authors)
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
Open Access
Published: May 2021
11 citations
11 citations
1097 days after retraction
Low Plasma Citrate Levels and Specific Transcriptional Signatures Associated with Quiescence of CD34+ Progenitors Predict Azacitidine Therapy Failure in MDS/AML Patients
Pavla Kořalková, Monika Beličková, Dávid Kundrát et al. (17 authors)
Cancers
Open Access
Published: Apr 2021
2 citations
2 citations
1096 days after retraction
Epigenetic modulation of immune synaptic-cytoskeletal networks potentiates γδ T cell-mediated cytotoxicity in lung cancer
Rueyhung Roc Weng, Hsuan‐Hsuan Lu, Chien‐Ting Lin et al. (20 authors)
Nature Communications
Open Access
Published: Apr 2021
27 citations
27 citations
1078 days after retraction
Specific Protein 1 and p53 Interplay Modulates the Expression of the KCTD-Containing Cullin3 Adaptor Suppressor of Hedgehog 2
Annapaola Angrisani, A. Di Fiore, Claudia Augusta Di Trani et al. (12 authors)
Frontiers in Cell and Developmental Biology
Open Access
Published: Apr 2021
7 citations
7 citations
1074 days after retraction
A long intergenic non-coding RNA regulates nuclear localization of DNA methyl transferase-1
Rhian Jones, Susanne N. Wijesinghe, Claire Wilson et al. (6 authors)
iScience
Open Access
Published: Mar 2021
17 citations
17 citations
1042 days after retraction
DNA Methylation, Mechanisms of FMR1 Inactivation and Therapeutic Perspectives for Fragile X Syndrome
Veronica Nobile, C Pucci, Pietro Chiurazzi et al. (5 authors)
Biomolecules
Open Access
Published: Feb 2021
37 citations
37 citations
1023 days after retraction
Venetoclax for the treatment of elderly or chemotherapy-ineligible patients with acute myeloid leukemia: a step in the right direction or a game changer?
Sonal Agarwal, Andrew S. Kowalski, Molly Schiffer et al. (6 authors)
Expert Review of Hematology
Published: Jan 2021
6 citations
6 citations
994 days after retraction
Epigenetics
Richard L. Bennett, Jonathan D. Licht
Springer eBooks
Published: Jan 2021
977 days after retraction
Epigenetics
Richard L. Bennett, Jonathan D. Licht
Springer eBooks
Published: Jan 2021
977 days after retraction
Epigenetic regulation of inflammation in periodontitis: cellular mechanisms and therapeutic potential
Krzysztof T Jurdzinski, Jan Potempa, Aleksander M. Grabiec
Clinical Epigenetics
Open Access
Published: Nov 2020
95 citations
95 citations
945 days after retraction
Diagnosis and treatment of lymphomas in the era of epigenetics
Alain Chebly, Éliane Chouery, Joana Ropio et al. (8 authors)
Blood Reviews
Published: Nov 2020
12 citations
12 citations
932 days after retraction
Gene expression signatures associated with sensitivity to azacitidine in myelodysplastic syndromes
Kyuryung Kim, Silvia Park, Hayoung Choi et al. (9 authors)
Scientific Reports
Open Access
Published: Nov 2020
11 citations
11 citations
926 days after retraction
SRY-related high-mobility-group box 6 suppresses cell proliferation and is downregulated in breast cancer
Lei Zhang, Xiaochen Niu, Xinxin Zhang et al. (8 authors)
Anti-Cancer Drugs
Published: Oct 2020
5 citations
5 citations
891 days after retraction
Treatment of human cells with 5-aza-dC induces formation of PARP1-DNA covalent adducts at genomic regions targeted by DNMT1
Kostantin Kiianitsa, Yinbo Zhang, Nancy Maizels
DNA repair
Open Access
Published: Oct 2020
9 citations
9 citations
886 days after retraction
DNMT1-mediated Foxp3 gene promoter hypermethylation involved in immune dysfunction caused by arsenic in human lymphocytes
Yemei Ma, Ying Ye, Yining Liu et al. (10 authors)
Toxicology Research
Open Access
Published: Jul 2020
8 citations
8 citations
793 days after retraction
<i>In vitro</i> and <i>in vivo</i> induction of fetal hemoglobin with a reversible and selective DNMT1 inhibitor
Aidan G. Gilmartin, Arthur Groy, Elizabeth R. Gore et al. (23 authors)
Haematologica
Open Access
Published: Jun 2020
53 citations
53 citations
787 days after retraction
Methylation-Based Therapies for Colorectal Cancer
Klára Červená, Anna Siskova, Tomáš Büchler et al. (5 authors)
Cells
Open Access
Published: Jun 2020
45 citations
45 citations
786 days after retraction
Loss of PTEN sensitizes head and neck squamous cell carcinoma to 5-AZA-2’-deoxycytidine
Gabriell Bonifácio Borgato, Gabriel Álvares Borges, Ana Paula de Souza et al. (5 authors)
Oral Surgery Oral Medicine Oral Pathology and Oral Radiology
Published: May 2020
3 citations
3 citations
747 days after retraction
Epigenetic therapy remodels the immune synaptic cytoskeleton to potentiate cancer susceptibility to γδ T cells
Rueyhung Roc Weng, Hsuan‐Hsuan Lu, Chien‐Ting Lin et al. (20 authors)
bioRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: May 2020
733 days after retraction
A long intergenic non-coding RNA regulates nuclear localisation of DNA methyl transferase-1
Rhian Jones, Susanne N. Wijesinghe, John A. Halsall et al. (4 authors)
bioRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: Mar 2020
2 citations
2 citations
682 days after retraction
Clinical developments in epigenetic-directed therapies in acute myeloid leukemia
Darren Pan, Raajit K. Rampal, John Mascarenhas
Blood Advances
Open Access
Published: Mar 2020
19 citations
19 citations
679 days after retraction
5-Azacytidine inhaled dry powder formulation profoundly improves pharmacokinetics and efficacy for lung cancer therapy through genome reprogramming
Philip J. Kuehl, Carmen S. Tellez, Marcie J. Grimes et al. (15 authors)
British Journal of Cancer
Open Access
Published: Feb 2020
17 citations
17 citations
668 days after retraction
5-Azacitidine Induces NOXA to Prime AML Cells for Venetoclax-Mediated Apoptosis
Sha Jin, Dan Cojocari, Julie J. Purkal et al. (10 authors)
Clinical Cancer Research
Open Access
Published: Feb 2020
145 citations
145 citations
654 days after retraction
The effects of the DNA Demethylating reagent, 5-azacytidine on SMCHD1 genomic localization
Shabnam Massah, J. Jubene, Frank J.S. Lee et al. (5 authors)
BMC Genomic Data
Open Access
Published: Jan 2020
3 citations
3 citations
625 days after retraction
Molecular mechanisms underlying eicosapentaenoic acid inhibition of HDAC1 and DNMT expression and activity in carcinoma cells
Veronica Ceccarelli, Simona Ronchetti, M. Cristina Marchetti et al. (7 authors)
Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms
Published: Jan 2020
29 citations
29 citations
618 days after retraction
The Role of DNA Methylation in Cancer
Sepideh Shahkarami, Samaneh Zoghi, Nima Rezaei
Springer eBooks
Published: Jan 2020
2 citations
2 citations
611 days after retraction
Epigenetic Control Using Small Molecules in Cancer
Tomohiro Kozako, Yukihiro Itoh, Shin‐ichiro Honda et al. (4 authors)
Human perspectives in health sciences and technology
Published: Jan 2020
2 citations
2 citations
611 days after retraction
Dissection of demethylation and toxicity induced gene expression changes after decitabine treatment
Andrey Turchinovich, HM Surowy, AG Tonevitsky et al. (4 authors)
bioRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: Dec 2019
1 citation
1 citation
598 days after retraction
Sodium valproate and 5-aza-2′-deoxycytidine differentially modulate DNA demethylation in G1 phase-arrested and proliferative HeLa cells
Marina Amorim Rocha, Giovana M. B. Veronezi, Marina Barreto Felisbino et al. (6 authors)
Scientific Reports
Open Access
Published: Dec 2019
28 citations
28 citations
582 days after retraction
<p>DNA Methyltransferase Inhibitors: Catalysts For Antitumour Immune Responses</p>
Huimin Dan, Shanshan Zhang, Yongning Zhou et al. (4 authors)
OncoTargets and Therapy
Open Access
Published: Dec 2019
55 citations
55 citations
580 days after retraction
Epigenetic Control of Scleroderma: Current Knowledge and Future Perspectives
Pei‐Suen Tsou
Current Rheumatology Reports
Published: Dec 2019
14 citations
14 citations
580 days after retraction
Comparative analysis of epigenetic inhibitors reveals different degrees of interference with transcriptional gene silencing and induction of DNA damage
Anna Nowicka, Barbara Tokarz, Jana Zwyrtková et al. (14 authors)
The Plant Journal
Open Access
Published: Nov 2019
32 citations
32 citations
565 days after retraction
<p>5-Aza-CdR Regulates RASSF1A By Inhibiting DNMT1 To Affect Colon Cancer Cell Proliferation, Migration And Apoptosis</p>
Jinyuan Chen, Lixiang Wu, Hong Xu et al. (4 authors)
Cancer Management and Research
Open Access
Published: Nov 2019
10 citations
10 citations
550 days after retraction
A DNA aptamer for binding and inhibition of DNA methyltransferase 1
Linlin Wang, Ju Yong Lee, Linfeng Gao et al. (13 authors)
Nucleic Acids Research
Open Access
Published: Nov 2019
30 citations
30 citations
550 days after retraction
Recent Advances in the Targeting of Epigenetic Regulators in B-Cell Non-Hodgkin Lymphoma
Marcelo Lima Ribeiro, Diana Reyes-Garau, Marc Armengol et al. (5 authors)
Frontiers in Genetics
Open Access
Published: Oct 2019
28 citations
28 citations
534 days after retraction
Targeting DNA repair in cancer: current state and novel approaches
Apostolos Klinakis, Dimitris Karagiannis, Θεόδωρος Ράμπιας
Cellular and Molecular Life Sciences
Published: Oct 2019
86 citations
86 citations
532 days after retraction
Ube2b-dependent degradation of DNMT3a relieves a transcriptional brake on opiate-induced synaptic and behavioral plasticity
Zhong-Guo Chen, Yu-Jun Wang, Ruosong Chen et al. (11 authors)
Molecular Psychiatry
Published: Oct 2019
9 citations
9 citations
519 days after retraction
Genome Variation, the Epigenome and Cellular Phenotypes
Martina Baumann, Gerald Klanert, Sabine Vcelar et al. (6 authors)
Unknown Journal
Published: Sep 2019
2 citations
2 citations
508 days after retraction
Aberrant DNA Methylation in Acute Myeloid Leukemia and Its Clinical Implications
Xian‐Wen Yang, Molly Pui Man Wong, Ray Kit Ng
International Journal of Molecular Sciences
Open Access
Published: Sep 2019
90 citations
90 citations
504 days after retraction
Novel prodrugs of decitabine with greater metabolic stability and less toxicity
Naoko Hattori, Magoichi Sako, Kana Kimura et al. (8 authors)
Clinical Epigenetics
Open Access
Published: Aug 2019
40 citations
40 citations
458 days after retraction
Low doses of decitabine improve the chemotherapy efficacy against basal-like bladder cancer by targeting cancer stem cells
Mingqing Wu, Sheng Lü, Maosheng Cheng et al. (15 authors)
Oncogene
Published: Mar 2019
28 citations
28 citations
331 days after retraction
An oral fixed-dose combination of decitabine and cedazuridine in myelodysplastic syndromes: a multicentre, open-label, dose-escalation, phase 1 study
Michael R. Savona, Olatoyosi Odenike, Philip C. Amrein et al. (13 authors)
The Lancet Haematology
Published: Mar 2019
111 citations
111 citations
331 days after retraction
Negative Regulation of p53-Induced Senescence by N-WASP Is Crucial for DMBA/TPA-Induced Skin Tumor Formation
Hui Li, Simon Petersen, Alberto Garcia Mariscal et al. (4 authors)
Cancer Research
Open Access
Published: Mar 2019
15 citations
15 citations
324 days after retraction
Epigenetic therapy in hematological cancers
Konstantinos Dimopoulos, Kirsten Grønbæk
Apmis
Open Access
Published: Mar 2019
25 citations
25 citations
316 days after retraction
FMR1 Reactivating Treatments in Fragile X iPSC-Derived Neural Progenitors In Vitro and In Vivo
Dan Vershkov, Nina Fainstein, Sapir Suissa et al. (6 authors)
Cell Reports
Open Access
Published: Mar 2019
35 citations
35 citations
305 days after retraction
OAS-RNase L innate immune pathway mediates the cytotoxicity of a DNA-demethylating drug
Shuvojit Banerjee, Elona Gusho, Christina Gaughan et al. (13 authors)
Proceedings of the National Academy of Sciences
Open Access
Published: Feb 2019
69 citations
69 citations
303 days after retraction
Related Records
This article has multiple records in the database due to different notices:
Record #36485
Apr 12, 2022Quick Stats
Total Citations:
386
Years Since Retraction:
7.6 years
Open Access:
Yes
Last Checked:
Never